(13-356) Assessing Discontinuation Rates of Oral vs. Injectable Buprenorphine After One Year of Treatment
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: Marshall Health- Ambulatory Care Clinics Residency Program Type: PGY1 (Community-Based Pharmacy) Residency Program Location: West Virginia
Co-Author(s): Todd Davies, Ronald Carico Jr., Andrew Riffe
